SuperworthArmata Pharmaceuticals shares outstanding ARMP
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 62M
- On a year earlier
- +71.4%
- more shares
Armata Pharmaceuticals had 62M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 71.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 36.4M | −38% |
| FY2024 | 59.1M | +64% |
| FY2023 | 36.1M | +0% |
| FY2022 | 36M | +37% |
| FY2021 | 26.3M | +43% |
| FY2020 | 18.4M | +93% |
| FY2019 | 9.5M | +351% |
| FY2018 | 2.1M | +210% |
| FY2017 | 681.2K | +604% |
| FY2016 | 96.8K | +130% |
| FY2015 | 42.1K | +51% |
| FY2014 | 28K | +33% |
| FY2013 | 21K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 62M | +71% | |
| Q1 FY26 | 36.5M | −39% | |
| Q4 FY25 | 36.4M | −38% | |
| Q3 FY25 | 36.2M | +0% | |
| Q2 FY25 | 36.2M | −38% | |
| Q1 FY25 | 59.5M | +65% | |
| Q4 FY24 | 59.1M | +64% | |
| Q3 FY24 | 36.2M | +0% | |
| Q2 FY24 | 58.2M | +3% | |
| Q1 FY24 | 36.1M | +0% | |
| Q4 FY23 | 36.1M | +0% | |
| Q3 FY23 | 36.1M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Armata Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.